Treatment of Hypertension (abnormally high blood pressure) with herbal Unani medicine

Evaluation of safety and efficacy of Zaranbad (Curcuma zedoaria Rosc.) in Primary hypertension- a randomized standard control trial. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055796

Enrollment

Registered

2023-07-28

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Zaranbad (Curcuma Zedoria Rosc): in the Form of Capsule through Oral route Dose 1g twice daily with plain water Follow up 1st week 2nd week 3rd week and 4th week Method of preparation

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of grade1 hypertension

Exclusion criteria

Exclusion criteria: Pregnant and lactating women. Patients suffering from any other systemic diseases. Patients suffering from secondary hypertension

Design outcomes

Primary

Measure	Time frame
Change in systolic & diastolic blood pressureTimepoint: Change in systolic & diastolic blood pressure baseline to end of treatment & every followup	—

Secondary

Measure	Time frame
Quality of life MINICHALTimepoint: baseline & after treatment	—

Countries

India

Contacts

Public ContactDr Nazim Husain

Luqman Unani Medical College Hospital and Research Centre

Shaziafarooquinium@gmail.com8147438868

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026